Ticker Talk

Shares of Santa Barbara-based Inamed Corp. (IMDC) fell 10% on Tuesday after a Food and Drug Administration expert panel recommended the agency reject the medical-device maker’s weight-loss product. Inamed slid $4.56 to $40.44 on Nasdaq, but the stock still is up 173% in the last 12 months. Panel members said they wanted to see how patients fared in losing weight over a longer period than the two years covered by the company’s studies of the product, called Lap-Band, an implantable device designed to treat extreme obesity by cinching off part of the stomach. The decision should delay--not derail--the company’s effort to bring the product to the U.S. market, analysts said. . . . Broadcom Corp. (BRCM) jumped 13% after Standard & Poor’s said the No. 1 maker of chips for cable modems will be added to the S&P; 500 index. The Irvine-based company’s stock climbed $19.30 to $166.80. Broadcom will replace GTE Corp. which is being bought by Bell Atlantic, in the index at a date to be announced.